Atossa Therapeutics Inc (NASDAQ:ATOS) has a beta value of 1.27 and has seen 0.46 million shares traded in the recent trading session. The company, currently valued at $196.09M, closed the recent trade at $1.57 per share which meant it gained $0.04 on the day or 2.29% during that session. The ATOS stock price is -47.13% off its 52-week high price of $2.31 and 62.42% above the 52-week low of $0.59. The 3-month trading volume is 1.69 million shares.

Atossa Therapeutics Inc (NASDAQ:ATOS) trade information

Sporting 2.29% in the green today, the stock has traded in the green over the last five days, when the ATOS stock price touched $1.57 or saw a rise of 1.57%. Year-to-date, Atossa Therapeutics Inc shares have moved 77.84%, while the 5-day performance has seen it change 10.21%. Over the past 30 days, the shares of Atossa Therapeutics Inc (NASDAQ:ATOS) have changed -13.06%.

Atossa Therapeutics Inc (ATOS) estimates and forecasts

Figures show that Atossa Therapeutics Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 132.99% over the past 6 months, with this year growth rate of -16.67%, compared to 14.60% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2024 fiscal year revenue. Growth estimates for the current quarter are -20.00% and 25.00% for the next quarter.

2 analysts offering their estimates for the company have set an average revenue estimate of -$ for the current quarter. 2 have an estimated revenue figure of -$ for the next quarter concluding in Jun 2024.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 46.61% over the past 5 years.

ATOS Dividends

Atossa Therapeutics Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.